Navigation Links
CyVek, Inc. Secures $5.5 Million in Series D Financing
Date:2/4/2013

WALLINGFORD, Conn., Feb. 4, 2013 /PRNewswire/ -- CyVek, Inc., an innovator in multi-analyte immunoassay technology, announced today that it has secured a Series D round of financing in the amount of $5.5 million.  Connecticut Innovations and a group of private investors participated in the round.

The Series D funding enables the company to create the infrastructure needed to commercialize its novel immunoassay technology, CyPlex™, an integrated test system which includes a proprietary microfluidic cartridge that allows the analysis of multiple biomarkers from very small amounts of biological samples.  This technology has broad appeal in research and clinical applications.  Initially the CyVek system will be used in biomarker analysis in life sciences, drug discovery and clinical research.  CyVek is currently in the beta testing phase.

Per Hellsund , CyVek founder, President and CEO, commented, "We are very pleased to have closed our Series D financing. The funding provided by our investors will enable us to complete development related activities and put together the team and infrastructure required to commercialize.  CyPlex™ continues to demonstrate excellent reproducibility coupled with unprecedented ease of use and will provide exceptional value to researchers and clinicians alike.  We have had extremely positive feedback from early customers and this validates our vision of CyVek fulfilling unmet needs in basic research, translational research and clinical diagnostics."

CyVek was formed in 2010 and is led by an experienced team of researchers and business executives who have developed and commercialized technologies, launched products, driven sales, negotiated partnerships, and led companies from start up to liquidity events.

About CyVek Inc.

CyVek is a privately funded biotechnology company dedicated to t
'/>"/>

SOURCE CyVek, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amarantus BioScience Secures an Additional $1.4 Million in Financing Commitments
2. Topokine Therapeutics Secures Financing from Schooner Capital to Advance Clinical Development of XAF5 Gel
3. Unisense FertiliTech A/S Secures 24 Million USD in New Capital Investment
4. Biomatrica Secures Financing of $5 Million
5. SurgiQuest, Inc. Secures Additional $18.5 Million Funding to Fuel Worldwide Expansion and Commercialization Efforts
6. Zafgen Secures $21 Million in Series D Financing
7. Flexion Therapeutics Secures $20 Million in Series B Financing
8. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
9. ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
10. BioMotiv Secures $21 million in Initial Funding
11. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... VEGAS , Jan. 23, 2015 Cord Blood America, ... ) ("CBAI" or the "Company")  filed a Preliminary Proxy Statement, ... www.sec.gov ) today, and provides an update for shareholders detailing ... shares is requested. Dear Shareholders, As ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft ... Company,s Phase 2 clinical trial.  This open-label study will ... GPX-150 (an investigational medication), in approximately 30 adults as ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 ...
(Date:1/22/2015)... 2015  BiOptix is pleased to announce the appointment of ... Chemistry and Biochemistry. Scott joins the company after previous scientific ... throughout the course of his nearly 20 year career ... a nationally recognized thought leader in the biosensor field ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... Dey Pharma, L.P. today announced that it has ... specialty pharma company headquartered in Sweden, for the exclusive ... Europe. EpiPen Auto-Injector is used for emergency treatment of ... within a couple of minutes, and may be life-threatening. ...
... BURLINGTON, Mass., Dec. 23, 2010 Decision Resources, one of ... healthcare issues, finds that 60 percent of surveyed type 2 ... they would request that their doctor switch them to a ... The new Patient Forum report entitled ...
Cached Medicine Technology:Mylan's Dey Pharma Partners with Meda to Market EpiPen® Auto-Injector in Europe 2Mylan's Dey Pharma Partners with Meda to Market EpiPen® Auto-Injector in Europe 3Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available 2
(Date:1/22/2015)... 22, 2015 Deer Path of Huntley ... Valentine’s Day Happy Hour from 3 p.m. to 4 p.m. on ... Parkway in Huntley, Illinois, serves adults with physical disabilities between the ... include Valentine's Day treats, games and sweetheart-themed karaoke. , For more ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Liberty University has ... (M.A.) program from the Council for Accreditation of ... part of Liberty’s Center for Counseling & Family Studies ... dean of the university’s new School of Behavioral Sciences. Prior ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference ... 42nd anniversary of the Supreme Court decision Roe v. Wade, which ... since the Roe vs. Wade decision and the fight to protect ... said City of West Hollywood Councilmember Abbe Land. “We need to ...
(Date:1/22/2015)... 2015 Gabe’s Chemo Duck Program is pleased to ... app ever created for kids with cancer. The Chemo Duck App, ... is filled with enjoyable games to help children of all ages ... app helps to keep kids entertained, educated and at ease while ...
(Date:1/22/2015)... a seasoned and trusted leader who consistently delivers trendy dresses ... it lead the wedding dress industry into the future. Today, ... the global market. , “The CEO of VogueQueen is uniquely ... continuing the goal of operational excellence and giving back to ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2
... obesity stats, the American Heart Association (AHA) is calling on schools ... ,"Kids spend a lot of time in the schools for a ... physically active as they need in order to be healthy, schools ... chairman of the group that framed nine practical steps to see ...
... Journal has noted that there has been an alarming ... now accounts for one fifth of the world's population ... food habits, changes in lifestyle, and reduced physical activity ... ,About 184 million people were estimated ...
... a tendency of occurring in the morning as against ... early evening. ,This fact was revealed when they ... an intracerebral hemorrhage, or a subarachnoid hemorrhage. The presence ... 8 a.m peak, and the 6 p.m. to 8 ...
... will approve the plan for six new private finance initiative ... in their budgets. ,The announcement has signaled the ... the history of the NHS but has infuriated public health ... to hold down NHS deficits. ,Under the plans, ...
... According to a research that was published in Nature, ... the roundworm Caenorhabditis// elegans also decrease the growth of ... why cancer risk increases as we grow older, and ... , Professor Cynthia Kenyon and colleagues from the University ...
... in India's Andaman and Nicobar Islands who lost their parents ... to get over their trauma, says a new report.//, ... researchers Shivani Chaudhary and Enakshi Ganguly Thukral - says a ... rehabilitation efforts., ,Bhushan, now a healthy boy, was barely ...
Cached Medicine News:Health News:Proposal to Build Six new Hospitals Met with Rage 2Health News:Long-life genes - A new way to combat cancer… 2Health News:Long-life genes - A new way to combat cancer… 3Health News:Post-tsunami trauma still haunts children 2
Incontinence Pessaries...
Incontinence Pessaries...
Indications: for young women who experience stress urinary incontinence when excercising vigorously; i.e., aerobics, tennis, jogging....
The donut pessary is designed for third degree prolapse as well as cystocele and rectocele. The soft donut can be compressed for insertion. It is available in seven sizes....
Medicine Products: